Phase II Study Of STI571 (GleevecTM) For Patients With Small Cell Lung Cancer

Reviewer: Roberto Santiago, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 21 de mayo del 2002

Translation for this article does not exist